肝肺综合征和肝移植后并发症:一项病例对照研究。

IF 0.3 Q4 TRANSPLANTATION
A Morvan, M Gazon, S Duperret, Z Schmitt, P Pradat, K Mohkam, F Aubrun
{"title":"肝肺综合征和肝移植后并发症:一项病例对照研究。","authors":"A Morvan,&nbsp;M Gazon,&nbsp;S Duperret,&nbsp;Z Schmitt,&nbsp;P Pradat,&nbsp;K Mohkam,&nbsp;F Aubrun","doi":"","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Although liver transplantation (LT) improves survival in cirrhotic patients with hepatopulmonary syndrome (HPS), few data exist concerning post-operative complications in these patients.</p><p><strong>Objective: </strong>To compare complications after LT between patients with and without HPS.</p><p><strong>Methods: </strong>In a case-control study, we retrospectively analyzed all patients who underwent LT in our center from January 2010 to July 2016. We compared cases of identified HPS to controls matched for age, MELD score, comorbidities, red blood cells transfused, and highest dosage of norepinephrine perfused during transplantation.</p><p><strong>Results: </strong>Among 451 transplanted patients, we identified 71 patients with HPS who could be analyzed. We found a significantly (p<0.001) higher number of post-operative complications in patients with HPS (median 5 <i>vs</i> 3), with more occurrence of cardiac, infectious and surgical complications than in the controls: 39.4% <i>vs</i> 12.7% (p<0.001), 81.7% <i>vs</i> 49.3% (p<0.001), and 59.2% <i>vs</i> 40.1% (p<0.029), respectively. There were also more ICU readmissions at 1 month among HPS patients (10 <i>vs</i> 1, p=0.01). There was no significant difference concerning ventilation data, lengths of ICU or hospital stay (8.5 [range 3-232] and 32 [14-276] days, respectively on the whole cohort) and death in the ICU (4.2% on the whole cohort). The 1-year survival was higher in HPS patients (94.4% <i>vs</i> 81.1%, p=0.034); there was no difference in 5-year survival.</p><p><strong>Conclusion: </strong>HPS patients seem to have a higher number of complications in the first month following LT.</p>","PeriodicalId":14242,"journal":{"name":"International Journal of Organ Transplantation Medicine","volume":"11 4","pages":"166-175"},"PeriodicalIF":0.3000,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7726840/pdf/ijotm-11-166.pdf","citationCount":"0","resultStr":"{\"title\":\"Hepatopulmonary Syndrome and Post-Liver Transplantation Complications: A Case-Control Study.\",\"authors\":\"A Morvan,&nbsp;M Gazon,&nbsp;S Duperret,&nbsp;Z Schmitt,&nbsp;P Pradat,&nbsp;K Mohkam,&nbsp;F Aubrun\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Although liver transplantation (LT) improves survival in cirrhotic patients with hepatopulmonary syndrome (HPS), few data exist concerning post-operative complications in these patients.</p><p><strong>Objective: </strong>To compare complications after LT between patients with and without HPS.</p><p><strong>Methods: </strong>In a case-control study, we retrospectively analyzed all patients who underwent LT in our center from January 2010 to July 2016. We compared cases of identified HPS to controls matched for age, MELD score, comorbidities, red blood cells transfused, and highest dosage of norepinephrine perfused during transplantation.</p><p><strong>Results: </strong>Among 451 transplanted patients, we identified 71 patients with HPS who could be analyzed. We found a significantly (p<0.001) higher number of post-operative complications in patients with HPS (median 5 <i>vs</i> 3), with more occurrence of cardiac, infectious and surgical complications than in the controls: 39.4% <i>vs</i> 12.7% (p<0.001), 81.7% <i>vs</i> 49.3% (p<0.001), and 59.2% <i>vs</i> 40.1% (p<0.029), respectively. There were also more ICU readmissions at 1 month among HPS patients (10 <i>vs</i> 1, p=0.01). There was no significant difference concerning ventilation data, lengths of ICU or hospital stay (8.5 [range 3-232] and 32 [14-276] days, respectively on the whole cohort) and death in the ICU (4.2% on the whole cohort). The 1-year survival was higher in HPS patients (94.4% <i>vs</i> 81.1%, p=0.034); there was no difference in 5-year survival.</p><p><strong>Conclusion: </strong>HPS patients seem to have a higher number of complications in the first month following LT.</p>\",\"PeriodicalId\":14242,\"journal\":{\"name\":\"International Journal of Organ Transplantation Medicine\",\"volume\":\"11 4\",\"pages\":\"166-175\"},\"PeriodicalIF\":0.3000,\"publicationDate\":\"2020-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7726840/pdf/ijotm-11-166.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International Journal of Organ Transplantation Medicine\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"TRANSPLANTATION\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Organ Transplantation Medicine","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"TRANSPLANTATION","Score":null,"Total":0}
引用次数: 0

摘要

背景:虽然肝移植(LT)可以提高肝硬化肝肺综合征(HPS)患者的生存率,但很少有关于这些患者术后并发症的数据。目的:比较HPS患者和非HPS患者肝移植术后并发症。方法:在一项病例对照研究中,我们回顾性分析了2010年1月至2016年7月在本中心接受肝移植的所有患者。我们比较了年龄、MELD评分、合并症、红细胞输注和移植过程中灌注去甲肾上腺素的最高剂量相匹配的HPS病例和对照组。结果:在451例移植患者中,我们确定了71例可分析的HPS患者。我们发现(pvs3),心脏、感染和手术并发症的发生率比对照组高:39.4%比12.7% (pvs49.3%) (pvs40.1% (pvs1, p=0.01)。通气数据、ICU时间或住院时间(全队列分别为8.5天[范围3-232]和32天[14-276])和ICU死亡(全队列为4.2%)方面无显著差异。HPS患者的1年生存率较高(94.4% vs 81.1%, p=0.034);5年生存率无差异。结论:HPS患者在肝移植后的第一个月似乎有更多的并发症。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Hepatopulmonary Syndrome and Post-Liver Transplantation Complications: A Case-Control Study.

Background: Although liver transplantation (LT) improves survival in cirrhotic patients with hepatopulmonary syndrome (HPS), few data exist concerning post-operative complications in these patients.

Objective: To compare complications after LT between patients with and without HPS.

Methods: In a case-control study, we retrospectively analyzed all patients who underwent LT in our center from January 2010 to July 2016. We compared cases of identified HPS to controls matched for age, MELD score, comorbidities, red blood cells transfused, and highest dosage of norepinephrine perfused during transplantation.

Results: Among 451 transplanted patients, we identified 71 patients with HPS who could be analyzed. We found a significantly (p<0.001) higher number of post-operative complications in patients with HPS (median 5 vs 3), with more occurrence of cardiac, infectious and surgical complications than in the controls: 39.4% vs 12.7% (p<0.001), 81.7% vs 49.3% (p<0.001), and 59.2% vs 40.1% (p<0.029), respectively. There were also more ICU readmissions at 1 month among HPS patients (10 vs 1, p=0.01). There was no significant difference concerning ventilation data, lengths of ICU or hospital stay (8.5 [range 3-232] and 32 [14-276] days, respectively on the whole cohort) and death in the ICU (4.2% on the whole cohort). The 1-year survival was higher in HPS patients (94.4% vs 81.1%, p=0.034); there was no difference in 5-year survival.

Conclusion: HPS patients seem to have a higher number of complications in the first month following LT.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
1.60
自引率
0.00%
发文量
0
审稿时长
12 weeks
期刊介绍: The International Journal of Organ Transplantation Medicine (IJOTM) is a quarterly peer-reviewed English-language journal that publishes high-quality basic sciences and clinical research on transplantation. The scope of the journal includes organ and tissue donation, procurement and preservation; surgical techniques, innovations, and novelties in all aspects of transplantation; genomics and immunobiology; immunosuppressive drugs and pharmacology relevant to transplantation; graft survival and prevention of graft dysfunction and failure; clinical trials and population analyses in the field of transplantation; transplant complications; cell and tissue transplantation; infection; post-transplant malignancies; sociological and ethical issues and xenotransplantation.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信